Main Article Content
Abstract
Background: Acute coronary syndrome (ACS) complicated by heart failure (HF) represents a distinct, high-risk phenotype. Even after successful revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), these patients remain vulnerable to maladaptive ventricular remodeling and functional decline. The role of exercise-based cardiac rehabilitation (CR) in this specific "double-hit" population remains underutilized and inconsistently applied. This study aimed to evaluate the effectiveness of exercise-based CR on functional capacity, left ventricular ejection fraction (LVEF), and major adverse cardiac and cerebrovascular events (MACCE) in patients with ACS complicated by HF following revascularization.
Methods: We conducted a systematic review and meta-analysis of randomized controlled trials and high-quality cohort studies published between 2019 and 2025. Seven pivotal studies involving 23,663 participants were analyzed. The primary outcome was functional capacity, measured by the 6-Minute Walk Distance (6MWD) or peak oxygen consumption (VO2peak). Secondary outcomes included LVEF and MACCE. Data were pooled using random-effects models.
Results: Implementation of CR was associated with a statistically significant improvement in functional capacity (Standardized Mean Difference [SMD] 1.66; 95% Confidence Interval [CI] 0.11–3.22; p=0.04). Cardiac function analysis revealed a clinically meaningful increase in LVEF (Mean Difference +2.58%; 95% CI -0.29 to 5.46; p=0.08) in the CR group. Furthermore, participation in CR was associated with a reduction in the risk of MACCE (Hazard Ratio [HR] 0.80; 95% CI 0.62–1.03; p=0.09), with long-term survival benefits observed in large cohort subsets.
Conclusion: Exercise-based CR provides critical physiological benefits beyond those achieved by revascularization alone. The significant restoration of functional capacity and favorable effects on cardiac remodeling underscore CR as an essential, non-negotiable pillar of care for patients with ACS complicated by heart failure.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
